Revolutions Medical Corporation is Proud to Announce the Launch of a Strategic Partnership With Santa Monica Pharmaceutica Ltda, in Brazil

CHARLESTON, S.C., May 12, 2010 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation (“Revmed” or the “Company”) (OTCBB:RMCP), has signed an agreement of understanding for the setting up of a manufacturing facility in Brazil to produce the RevVac safety syringe for domestic and global markets and to facilitate distribution throughout South America.

MORE ON THIS TOPIC